Aspiriant LLC’s Northrop Grumman NOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.78M Buy
+2,603
New +$1.8M 0.05% 120
2024
Q2
Sell
-431
Closed -$206K 317
2024
Q1
$206K Hold
431
0.01% 306
2023
Q4
$202K Sell
431
-207
-32% -$97K 0.01% 299
2023
Q3
$281K Buy
+638
New +$280K 0.01% 235
2023
Q1
Sell
-435
Closed -$237K 289
2022
Q4
$237K Buy
+435
New +$227K 0.01% 241

Other funds holding NOC

Aspiriant LLC's NOC Position: Q1 2026 in Review

Aspiriant LLC opened a new position in Northrop Grumman (NOC) in Q1 2026: 2,603 shares worth $1.78M. The stake represents 0.05% of the portfolio and ranks #120 among its holdings. This is a return to the name: Aspiriant LLC previously reported a position in NOC as recently as Q1 2024.

Aspiriant LLC first reported a position in NOC in Q4 2022 and has held it in 5 quarters since. 1,875 funds tracked by Wall St. Rank hold NOC as of Q1 2026.

  • Aspiriant LLC held 2,603 shares of Northrop Grumman worth $1.78M as of Q1 2026.
  • Northrop Grumman was a new Aspiriant LLC position in Q1 2026.
  • Northrop Grumman made up 0.05% of Aspiriant LLC's portfolio in Q1 2026, its #120 holding.
  • Aspiriant LLC first reported a position in Northrop Grumman in Q4 2022 and has held it in 5 quarters since.
  • 1,875 funds tracked by Wall St. Rank held Northrop Grumman as of Q1 2026.

Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.